Dentsply Sirona Beats Q2 Estimates, Keeps 2026 Guidance

Earnings

โดย Zacks Investment Research·Read original

Summary · why it matters

Dentsply Sirona Inc. reported second-quarter adjusted earnings of 52 cents per share, beating the Zacks Consensus Estimate of 36 cents by 44.4%, while revenues of $898 million topped expectations by 1.6%, despite a 4.1% year-over-year decline as reported and a 6.3% drop at constant currency. The company maintained its 2026 net sales outlook of $3.5 billion to $3.6 billion and adjusted earnings guidance of $1.40-$1.50 per share, excluding tariff refund benefits. Wellspect Healthcare was the bright spot, with revenues up 7.1% to $86 million, while Connected Technology Solutions fell 1.5%, Essential Dental Solutions declined 2.7%, and Orthodontic and Implant Solutions dropped 13.2%. Adjusted gross margin improved 50 basis points to 56.4%, and adjusted EBITDA margin rose 20 basis points to 21.3%, but adjusted operating margin contracted 240 basis points to 15.8% due to lower volumes, unfavorable mix, tariff costs, and higher expenses. Free cash flow increased to $55 million from $16 million a year earlier, though cash and equivalents fell to $239 million from $326 million at year-end 2025, with net debt-to-EBITDA at 3.2.

Dentsply Sirona Inc ▲